HEALTHPEAK PROPERTIES, INC.
Close on Oct 19, 2026
- Market cap
- $12.69B
- P/E (TTM)
- 52.6
- Dividend yield
- 6.63%
About Healthpeak Properties
Real Estate Investment Trusts, SIC 6798
Healthpeak Properties, Inc. is a self-administered real estate investment trust focused on acquiring, developing, and operating healthcare discovery and delivery real estate across the United States. Its primary business segments consist of outpatient medical properties, life science laboratory facilities, and senior housing communities. The outpatient medical division encompasses outpatient facilities, medical clinics, and specialized hospitals, while the lab segment provides multi-building campus properties with specialized research infrastructure. The company's clients primarily include hospital networks, healthcare delivery systems, specialty medical groups, and commercial biotechnology, pharmaceutical, and medical device organizations.
As of late 2025, the company held interests in 689 properties nationwide, comprising 507 outpatient medical buildings, 145 lab facilities, 34 senior housing properties, and three additional holdings. Its laboratory real estate is concentrated within major scientific research hubs in San Francisco, Boston, and San Diego. Healthpeak Properties is headquartered in Denver, Colorado, and maintains regional corporate offices in California, Massachusetts, Tennessee, and Wisconsin.
Summary of the business section of Healthpeak Properties's latest annual report, written by StockData.
Company profile
Company
- Legal name
- HEALTHPEAK PROPERTIES, INC.
- Founded
- 1985
- Headquarters
- Denver, CO
- Address
- 4600 South Syracuse Street, Suite 500 80237
- Phone
- (949) 407-0700
- Website
- www.hcpi.com
- Employees
- 411, Dec 31, 2025
- Industry
- Real Estate Investment Trusts
- Incorporated in
- Maryland
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Costa Mesa, California
Stock & identifiers
- Ticker
- DOC
- Exchange
- NYSE
- IPO date
- May 23, 1985
- Shares outstanding
- 690M, Aug 3, 2026
- Public float
- $9.40B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Mar 2, 2004; 2-for-1, May 21, 1992
- SEC CIK
- 765880
- CUSIP
- 42250P103
- ISIN
- US42250P1030
- LEI
- 254900M6MTMZM0I22L81
- EIN
- 33-0091377
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Scott M. Brinker | President and CEO, Director | 214,688 |
| Shawn G. Johnston | EVP and CAO | 42,336 |
| Kelvin O. Moses | Chief Financial Officer | 1,627 |
| Ankit B. Patadia | EVP and Treasurer | 9,047 |
| Adam G. Mabry | CIO | 5,097 |
| Scott R. Bohn | CDO and Head of Lab | 7,636 |
| Lisa A. Alonso | EVP and Chief HR Officer | 22,271 |
| Tracy A. Porter | EVP and General Counsel | 0 |
| Peter A. Scott | CFO | 164,339 |
| Jeffrey H. Miller | General Counsel | 46,837 |
| Thomas Klaritch | COO | 409,008 |
| John T. Thomas | Director | 830,111 |
| Katherine M. Sandstrom | Director | 76,669 |
| Brian G. Cartwright | Director | 83,490 |
| R. Kent Griffin Jr | Director | 90,195 |
| Sara Grootwassink Lewis | Director | 87,488 |
| James B. Connor | Director | 38,179 |
| Ava Lias-Booker | Director | 45,305 |
| Richard A. Weiss | Director | 79,469 |
| Tommy G. Thompson | Director | 144,290 |
| Pamela Shelley-Kessler | Director | 55,892 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Scott M.Brinker | $10.07M | $3.35M | $2.79M | $69 | $127 |
| FY2024 Mr Brinker | $8.47M | $10.25M | $3.28M | $75 | $118 |
| FY2024 Scott M.Brinker | $8.47M | $10.25M | $3.28M | $75 | $118 |
| FY2023 Mr Brinker | $7.69M | $2.50M | $3.00M | $69 | $112 |
| FY2023 Scott M.Brinker | $7.69M | $2.50M | $3.00M | $69 | $112 |
| FY2022 | – | $19.91M | $3.27M | $83 | $101 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“Our employees represent our greatest asset, and as of December 31, 2025, we had 411 full-time employees.”
Corporate history
Events identified from SEC filings